Ocugen Q2 2026 Net Loss $24.9M; Cash $100.1M; Going Concern Doubt

Ocugen reported a net loss of $24.9 million for Q2 2026, an increase from $14.7 million in Q2 2025. Despite this, the company significantly boosted its cash and cash equivalents to $100.1 million as of June 30, 2026, up from $18.6 million at year-end 2025, primarily due to recent financing activities. These activities included $112.5 million net proceeds from convertible senior notes, which also facilitated the repayment of $32.7 million in long-term debt. However, management expressed substantial doubt about the company's ability to continue as a going concern due to recurring operating losses and negative cash flows.